Literature DB >> 9347820

CD8+ lymphocytic pneumonitis in a patient receiving cyproterone acetate.

T Similowski1, B Orcel, J P Derenne.   

Abstract

A large number of drugs can induce pulmonary disease. We report the case of a female patient who was receiving cyproterone acetate for severe hirsutism. After 4 months of cyproterone therapy, she had dyspnea, pulmonary infiltrates, and a restrictive ventilatory defect. Bronchoalveolar lavage showed CD8+ lymphocytosis as well as increased neutrophils and eosinophils, a profile highly suggestive of an iatrogenic process. The patient showed no other significant clinical or biologic abnormality. Symptoms and functional abnormalities disappeared after withdrawal of cyproterone and reappeared after its reintroduction. This suggests that cyproterone acetate, a substance used to treat hirsutism and prostate cancer and in the composition of certain oral contraceptives, can be added to the list of drugs that may cause lymphocytic pneumonitis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9347820     DOI: 10.1097/00007611-199710000-00016

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  1 in total

1.  Interstitial pneumonitis secondary to leuprorelin acetate for prostate cancer.

Authors:  Hsern Ern Tan; Fiona Lake
Journal:  Respirol Case Rep       Date:  2016-03-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.